As of May 29, 2025, Althea Group Holdings Ltd (AGH.AX) reports a Gross Margin of 60.70%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Althea Group Holdings Ltd's Gross Margin
Over recent years, Althea Group Holdings Ltd's Gross Margin has shown a moderate pattern. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-06-30 | 60.70% |
| 2023-06-30 | 51.43% |
| 2022-06-30 | 47.47% |
| 2021-06-30 | 49.91% |
| 2020-06-30 | 59.09% |
This fluctuation highlights how Althea Group Holdings Ltd manages its operational efficiency and pricing power over time.
Comparing Althea Group Holdings Ltd's Gross Margin to Peers
To better understand Althea Group Holdings Ltd's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Althea Group Holdings Ltd (AGH.AX) | 60.70% |
| Auscann Group Holdings Ltd (AC8.AX) | 100.00% |
| Antisense Therapeutics Ltd (ANP.AX) | 97.91% |
| Pak Fah Yeow International Ltd (239.HK) | 86.22% |
| Kubota Pharmaceutical Holdings Co Ltd (4596.T) | 81.03% |
| Neurizon Therapeutics Ltd (PAA.AX) | 79.81% |
Compared to its competitors, Althea Group Holdings Ltd's Gross Margin is among the highest compared to peers, indicating superior product pricing power or cost efficiency in production.